(Q68758237)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3471936%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

title

Methotrexate bioavailability after oral and intramuscular administration in children (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3471936%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

1 reference

1 reference

M E Teresi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3471936%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

W R Crom

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3471936%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

K E Choi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3471936%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

J Mirro

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3471936%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

W E Evans

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3471936%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

language of work or name

English

0 references

publication date

1 May 1987

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3471936%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Pediatrics

27 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3471936%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

volume

110

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3471936%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3471936%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

page(s)

788-792

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3471936%20AND%20SRC:MED&resulttype=core&format=json

Comparison of intravenous and oral high-dose methotrexate in treatment of solid tumours

27 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980025-2

The bioavailability of oral intermediate-dose methotrexate. Effect of dose subdivision, formulation, and timing in the chemotherapy cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980025-2

Unpredictable serum levels after oral methotrexate in children with acute lymphoblastic leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980025-2

Small intestinal transit time affects methotrexate absorption in children with acute lymphoblastic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980025-2

Absorption of methotrexate under standardized conditions in children with acute lymphoblastic leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980025-2

Pharmacokinetics of low-dose methotrexate in children receiving maintenance therapy for acute lymphoblastic leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980025-2

Clinical pharmacodynamics of high-dose methotrexate in acute lymphocytic leukemia. Identification of a relation between concentration and effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980025-2

Evaluation of a fluorescence polarization immunoassay procedure for quantitation of methotrexate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980025-2

Clinical pharmacology of intermediate-dose oral methotrexate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980025-2

Bioavailability of methotrexate tablets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980025-2

Bioavailability of methotrexate: implications for clinical use

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980025-2

Enhancement of methotrexate absorption by subdivision of dose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980025-2

Can food influence the absorption of methotrexate in children with acute lymphoblastic leukaemia?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980025-2

Methotrexate and folate content of erythrocytes in patients receiving oral vs intramuscular therapy with methotrexate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980025-2

Serum profiles of methotrexate after its administration in children with acute lymphoblastic leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980025-2

Low-dose methotrexate kinetics in arthritis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980025-2

Comparison of serum concentrations of methotrexate after various routes of administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980025-2

10.1016/S0022-3476(87)80025-2

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3471936%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

1 reference